New antifungal drug could shield liver transplant patients from deadly infections
Disease control
ENROLLING_BY_INVITATION
This study tests whether a new antifungal drug called rezafungin can prevent serious fungal infections in people who have had a liver transplant. About 385 adults at high risk for infection will receive the drug, and their outcomes will be compared to similar patients from the pa…
Phase: PHASE3 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC